Partner Fund Management »

Ascendis Pharma AS shares owned by Partner Fund Management

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $62M 233k 266.72

More positions owned by Partner Fund Management

Ascendis Pharma A/s Ord Shs (ASND)
Axsome Therapeutics (AXSM)
Eli Lilly & Co. (LLY)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Humana (HUM)
UnitedHealth (UNH)
Neurocrine Biosciences (NBIX)
Inhibrx Biosciences (INBX)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Icon Pub SHS (ICLR)
Tenet Healthcare Corp Com New (THC)
Edwards Lifesciences (EW)
Waters Corporation (WAT)
Centene Corporation (CNC)

View all positions for Partner Fund Management

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS